J. E. Garber

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

Timothy R. Rebbeck, Albert M. Levin, Andrea Eisen et al. · JNCI Journal of the National Cancer Institute · 1999 · 676 citations · Full text

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

Janet Audrain, Barbara K. Rimer, David Cella et al. · Journal of Clinical Oncology · 1998 · 88 citations

Family Medicine, Counseling, Genetic Testing +21

Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy

Paula D. Ryan, Nadine Tung, SJ Isakoff et al. · Journal of Clinical Oncology · 2009 · 83 citations

Surgical Oncology, Breast Oncology, Medicine +15

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

J. E. Garber, Susan Halabi, Sara M. Tolaney et al. · JNCI Journal of the National Cancer Institute · 2010 · 62 citations · Full text

Brief Assessment of Parents' Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS)

Beth N. Peshkin, Tiffani A. DeMarco, J. E. Garber et al. · Journal of Pediatric Psychology · 2008 · 36 citations · Full text